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The goal of endodontic therapy is to retain infected teeth by eliminating pulpal 
and periapical disease. Young, infected permanent teeth with incomplete development of 
the root pose significant challenges in endodontic treatment. Chemo-mechanical 
disinfection with conventional debridement with endodontic files and irrigation can be 
challenging, and so is obturating the treated immature canal.1 Regenerative endodontic 
(RE) procedures have become acceptable treatments for these teeth. RE procedures can 
be defined as “biologically based procedures designed to replace damaged structures, 
including dentin and root structures, as well as cells of the pulp-dentin complex.”2 
Endodontic regenerative therapy aims to establish an environment that will enable 
continued root development, revascularization, and revitalization of the pulp tissue.  
Proper disinfection of the root canal system is a prerequisite for RE.3 
Stem cells, a scaffold, and cytokines/growth factors are the three major 
components needed to create an environment for successful RE to occur. Currently, a 
blood clot created in the canal serves as an endodontic scaffold.4 Bleeding is evoked from 
the apical tissues leading to the formation of a blood clot in the canal. The evoked-
bleeding step involves the manipulation of the periapical tissues, and stem cells are 
released and delivered into the root canal system.5 Soluble extracellular matrix molecules 
of dentin, pulp fibroblasts, and endothelial cells (EC) have also been shown to be 
involved in dentin-pulp regeneration.6 The blood clot scaffold is eventually replaced with 
pulp-like tissue and dentin pulp regeneration can be seen.6
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Failures in RE have been attributed to lack of vascularization, which could not 
support the blood clot scaffold.7 Angiogenesis is needed to increase vascularization and 
the creation of a vascular network. Different cell types and various cytokines/growth 
factors are involved in angiogenesis. These include endothelial cells, fibroblasts, 
neutrophils, and macrophages that produce vascular endothelial growth factor (VEGF).  
VEGF is a signaling protein that early in angiogenesis increases the permeability of blood 
vessels causing the extravasation of plasma proteins. This step leads to the creation of a 
temporary scaffold for migrating ECs.8  Macrophages produce tumor necrosis factor 
alpha (TNF-alpha), which also induces VEGF expression. In wound repair, VEGF 
expression is enhanced leading to a neovascular network that drives regeneration by 
increasing tissue perfusion.9 ECs have been shown to release the angiogenic cytokines 
fibroblast growth factor (FGF) and VEGF without any stimulation.6 VEGF increases the 
permeability of ECs and FGF promotes the proliferation and differentiation of ECs, 
smooth muscle cells, and fibroblasts.  
Matrix metalloproteinases (MMPs) play a role in angiogenesis by degrading 
matrix molecules and by activating or liberating the growth factors, such as basic 
fibroblast growth factor (bFGF), VEGF, and insulin-like growth factor 1 (IGF-1) that are 
within the extracellular matrix.8 Zehng et al. showed an increase in the expression of 
MMP-3, MMP-9 and MMP-13 after a pulpal injury.10 Tissue inhibitors of matrix 
metalloproteinases (TIMPs) play roles in the inhibition of MMPs, and thus, in inhibiting 
angiogenesis.  Mathieu et al. showed that ECs might play an important role in recruiting 
human pulp cells, as well as in forming the necessary blood vessels for angiogenesis.11   
4	  
	  
 
It is believed that an appropriate scaffold that provides an environment that supports ECs 
could improve the success of RE procedures.    
Alternative scaffolds to the blood clot scaffold are platelet-rich-plasma, synthetic 
scaffolds, and natural scaffolds.12 DynaMatrix® (Cook Biotech, West Lafayette, IN, 
USA) is a membrane currently used in dentistry for periodontal regeneration 
procedures.12,13 This acellular, three-dimensional extracellular matrix (ECM) is derived 
from porcine small intestine submucosa (SIS) and is composed of collagen that could be 
used as a framework for cell growth. The company states that it contains promoters of 
angiogenesis such as FGF-2, connective tissue growth factor (CTGF), and transforming 
growth factor beta (TGF-ß).13 Research at Indiana University School of Dentistry (IUSD) 
has shown that DynaMatrix® has potential as an endodontic scaffold.14,15  It can support 
the growth of human dental pulp stem cells (HDPSCs) and human dental pulp fibroblasts 
(HDPFs), and positive angiogenic profiles were seen after these cells were exposed to 
Dynamatrix®. The effects of DynaMatrix® on ECs and MMPs have not been 
investigated, although both are pivotal for angiogenesis. This work will further the 
evidence for the potential that DynaMatrix® has in RE. It will examine the angiogenic 
cytokine and MMP profiles of EC exposed to Dynamatrix.  
 
CLINICAL SIGNIFICANCE 
  DynaMatrix® membranes have been used successfully in medicine as scaffolds. 
Their ability to increase the angiogenic cytokine expression from endothelial cells will 
make them potential scaffolds for regenerative endodontics. 
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HYPOTHESES  
1. Null: There will be no significant differences in pro-angiogenic or anti-
angiogenic cytokines and in matrix metalloproteinases or tissue inhibitors of 
metalloproteinases expression or presence when HUVECs are seeded on the 
DynaMatrix® membrane as compared with the membrane or cells alone. 
2. Alternative: There will be a significant difference in pro-angiogenic or 
anti-angiogenic cytokines and in matrix metalloproteinases or tissue inhibitors of 
metalloproteinases expression or presence when HUVECs are seeded on the 
DynaMatrix® membrane when compared with the membrane or cells alone.   
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HISTORY OF ENDODONTICS 
One of the earliest descriptions of toothaches described as pain caused by cold 
and mastication was by Fu His in 2953 BC.16 For centuries descriptions of treatment for 
toothaches were described in Egyptian tablets, Hebrew Bibles, and medical writings of 
the Greeks, the Romans, and the Chinese. The Chinese theorized in the 14th century BC 
that dental disease was caused by tooth worms until it was disproved by the use of 
microscopes.17 
One of the first books in the English language that was considered to be 
exclusively devoted to dentistry was published in 1687 by Charles Allen.18 It described 
the treatment for teeth with dental transplants as “taking out the rotten teeth or stumps 
and putting in their places some sound ones drawn immediately out of some poor body’s 
head.” 19 
The Surgeon Dentist written by Pierre Fauchard in 1728 led many to consider him 
“the father of modern dentistry.”18 In his book, he described everything from anatomy, 
orthodontics, pathology, and the replacement of missing teeth. It also described the 
treatment of various teeth with pulp cavities and root canals. He also discussed treating 
abscessed teeth with access cavity preparations that were left open and eventually filled 
with lead foil.18 Fauchard also treated the pulp with oils, cinnamon, and even opium in 
deep carious lesions, for which he used a small pin for pulp extirpation.18  
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In 1756 Phillip Pfaff, a German dentist, described a pulp-capping procedure. He 
placed gold or lead over the exposed pulp. It was placed in such a way as to avoid direct 
contact with the pulpal tissues.18 
Bourdet described a procedure in 1757 that consisted of extracting carious teeth, 
filling the root canal with gold or lead, followed by replantation of the tooth.20 A similar 
procedure was described in the 11th century by an Arabian physician, Avicenna.20  
The first endodontic procedure to be recorded in North America was performed 
by Robert Woofendale..21 He came to New York from England in 1766 and his treatment 
consisted of cauterizing the pulp with a hot instrument followed by cotton pellet 
placement into the canals.21,22 Frederick Hirsh, a German dentist, in the 18th century, 
wrote about tenderness to percussion being associated with diseased teeth. His treatment 
suggestion was to use a red-hot probe repeatedly inserted into the cervical area of the 
tooth, and then to fill the tooth with lead.20 
“The Vitalistic Era” in the 19th century began as people began to become 
concerned with vitality and the problems this posed for treatment.18 J.B. Gariot in 1805 
suggested that obliteration of the pulp does not destroy the vitality of the tooth.18 Edward 
Hudson expanded on this and is often given credit for being the first to place fillings in 
root canals to preserve the natural dentition.21-25 
In Opinions on the Causes and Effects of Disease in the Teeth and Gums in 1819, 
John Callow gives Charles Bew credit for describing blood flow into the tooth from the 
apical foramen and out through the dentinal wall and through the periodontal 
membrane.23 This thought process, the “vitalistic theory,” was in line with others of his 
time. 23 Leonard Koecker, a German immigrant, wrote Principles of Dental Surgery.  
9	  
	  
 
This 1826 book was the standard in the field of dentistry for 50 years.25 He felt the tooth 
would become a foreign body after the pulp was destroyed, either by disease or 
artificially, and require the tooth to be extracted. To prevent the further extraction of 
teeth, Koecker popularized pulp capping similar to the manner in which Pfaff in 1756 
pulp capped teeth.23,26,27 
The vitalistic or double-membrane theory was formulated and presented by S. S. 
Fitch in 1829.18 In Systems of Dental Surgery, Fitch wrote about his belief that teeth were 
like hollow bones. He believed teeth consisted of an outer periosteum and an inner 
periosteum that was between the pulp and the dentin. With this double-membrane theory, 
he thought nourishment for the crown was exclusively from the dental pulp or lining 
membrane, and that the nourishment for the root was from the pulp membrane interiorly, 
and from the alveolar membrane exteriorly.18  
There was opposition to the vitalistic theory. British surgeon and anatomist John 
Hunter was of the “nonvitalistic” group. Hunter believed that dentin was not like living 
tissue and was lacking in many of the properties of living tissue, including circulation, 
sensibility, and the inability to repair.18 Cuvier and Robertson from England aligned with 
Hunter’s views.23  
The treatment of diseased pulpal tissues prior to 1836 was very unpleasant and 
painful.  Advancements in treatment began with Shearjashub Spooner in New York. He 
began using arsenic trioxide to devitalize the pulp before removing it.21 The Chinese used 
arsenic in ancient medicine practices for the treatment of abcesses of the jaw20  and its 
use continued until the 1920s for devitalization of the pulp before its removal.28 In 1837 
10	  
	  
 
Jacob and Joseph Linderer started using essential or narcotic oil for the treatment of 
exposed pulps.29  
Edwin Maynard in 1838 made the first broach for the removal of the pulpal tissue 
by filing down a watch spring. Maynard also designed hoe-like instruments for pulpal 
procedures. 29 The first mention of the removal of the nerve, of the cleaning of the canal, 
and of filling it with gold foil was by Baker in 1839.18,20 
Wooden plugs that were soaked in creosote were used in the 1850s to fill root 
canals. 18  They used a combination of sealer made with gutta-percha, quick-lime, 
powdered glass, feldspar, and metal filings with the wooden plug to seal the canal.28 
Thomas Rogers presented 220 cases of pulp capping at the Odontological Society 
of London meeting in 1857.18 Of his 220 cases, 202 were considered to be successful.18 
He outlined the conditions that when present are helpful in leading to successful pulp 
capping. These included:  general good health, freedom from inflammatory tendencies, 
absence of previous considerable pain from the tooth, absence of disease in other parts of 
the tooth, and no use of caustics to decrease the pain.18  
S.C. Barnum introduced the rubber dam for the placement of gold foil restorations 
in 1864.18 The use of the rubber dam was quickly adopted in the root canal filling 
procedure for a more aseptic environment.20,21 Many people credit G.A. Bowman of 
Missouri for being the first person to use gutta-percha alone for root canal fillings.21,24,30 
Bowman was also one of the inventors of the rubber dam clamp forceps in 1873.21 
Leber and Rottenstein’s work from Germany recognized that Leptothrix buccalis, 
a parasite, led to a better understanding of how tooth decay could cause gangrene or 
necrosis of the pulp.18,31 They found its existence on tooth surfaces, carious lesions, and 
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within the dentinal tubules.18,31 During the same year of 1867, Magitot suggested using 
electric current to test the pulp.26  
In the 1870s, another theory began to gain momentum over the vitalism theory.  
The septic theory, backed by G.O. Rogers and Charles S. Tomes, was the thought that 
pathologic organisms were the biggest cause for the disease of the pulp.23 Arthur 
Underwood expanded on the septic theory in 1882.23 He suggested that removal of 
pathogens from the pulp space, via antiseptics, could prevent pulpal suppuration and 
alveolar abscesses.18 For the next 30 years, this idea justified the use of caustic 
germicides for bacterial elimination from the pulp chamber.23  
In 1895 the discovery of x-rays by Wilhelm Konrad Roentgen helped to change 
the accuracy of dental diagnosis.32,33 Otto Walkhoff used Roentgen’s discovery to take 
radiographs of his own teeth and Edmund Kells took radiographs not only for diagnosis, 
but for endodontic treatment as well.32,33 Also, in 1895 Dr. Bowman introduced a 
combination of chloroform and gutta-percha, chloropercha, which was used with gutta-
percha cones to obturate the root canal. His technique was widely accepted among 
dentists.21  
Cocaine was used by Carl Koller in 1884 for a topical anesthetic.32,33 William 
Halsted performed mandibular block injections with a similar solution as Koller.32,33  
Funk in 1890 introduced pressure anesthesia using crystals of cocaine for pulp removal.32, 
33 Novocaine (procaine) developed in 1905 by Einhorn, provided dentistry with a more 
effective and less toxic anesthetic.28 Initially, the use of procaine was inefficient, 
requiring the dissolution of a tablet in a solution, boiling, cooling and aspiration into a 
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syringe.  It was not for nearly 25 years that the process for block anesthesia was 
perfected. 28,29,34 
Dr. Meyer L. Rhein developed a technique using radiographs and a diagnostic 
wire to determine the length of the canal and degree of obturation in 1908.21,26 Also, to 
avoid overfilling, G.V. Black suggested measurement control to determine the length of 
the canal and the size of the apical foramen.18 It was not until 1913 that the first dental x-
ray units were introduced.18   
Later in the 20th century, a shift in the medical and dental community led to what 
is now called the Focal Infection Theory.35 This theory was not new, but was gaining 
momentum in part due to the work of E.C. Rosenow. 35 The idea was that a large number 
of diseases were caused by microorganism including bacteria, fungi, and viruses that 
arise from within the individual to form a focus of infection.35 Rosenow demonstrated 
that streptococci were present in diseased organs.35 He also demonstrated that these 
bacteria could travel in the blood stream to establish an infection at a distant site within 
the organism.34 A significant boost to the focal infection theory that helped it to gain 
more widespread acceptance was due to William Hunter.18 Hunter, a British physician 
and pathologist, gave a lecture at McGill University in Montreal in 1910 called, “The 
Role of Sepsis and Antisepsis in Medicine.” It was later published in 1911 in Lancet.18 
This increase in the acceptance of the focal infection theory led to analysis of the validity 
of endodontic procedures among the dental and medical community. Because of this, 
many dentists and physicians recommended the extraction of all pulpless teeth. It was not 
until about 1930 that the pendulum began to swing to a more conservative approach.18 It 
was nearly a decade before this more conservative approach18 based on proper diagnosis, 
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aseptic techniques bacteriological culturing, and improved radiographic practices for root 
canal treatment36 was taught in dental schools.18  
During “the scientific era” in 1937, scientific evidence was moving toward more 
sound histological, biological, and pathological findings.18 Some of these scientific works 
by Logan were able to show that bacteria can be present in tissues without eliciting 
pathologic effects.22 Similarly, Tunnicliff and Hammond displayed that pulps of extracted 
teeth with microorganisms in them did not display any inflammatory changes.18,22 
Further, work by Cecil of Cornell Medical College demonstrated little improvement of 
arthritis after the removal of a suspected foci of infection.18 These results led Burket to 
his conclusion that the improvement following the removal of foci of infection was only a 
causal relationship.18,37 This body of evidence played a role in discouraging the practice 
of indiscriminate extraction of non-vital teeth and encouraged root canal therapy.18 
The use of antibiotics for root canal therapy was led by Fred Adams and Louis 
Grossman in the 1940s.18,34 Penicillin was first used by Adams, who also reported the use 
of sulfanilamide in the treatment of periapical infections.18,34 Dr. Grossman led the way 
for the use of an economical and more stable form of penicillin, and he used penicillin on 
paper points to disinfect root canals.24 
The formation in 1943 of the formation of the American Association of 
Endodontists (AAE) in Chicago, Illinois, signified the beginning of organized 
endodontics.38 A committee formed in 1949 to discuss the possibility of forming a 
specialty board for endodontics. Later, the American Board of Endodontics was formed 
in 1956.38 The next step was to gain recognition by the American Dental Association 
(ADA) as a specialty. Due to the relentless efforts of many AAE members and leaders, 
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the ADA officially recognized endodontics as a specialty in 1963.39 In 1965 the first 
certifications of Diplomat status were given.39 Currently, the AAE has around 7,000 
members with around one-fourth of them board certified.38 
 
THEORY OF ENDODONTICS 
The goal of endodontic therapy is to maintain form and function of teeth by the 
elimination of a microbial insult on the pulp and periapical tissues.40 This is 
accomplished through the study of the morphology, physiology and pathology of the pulp 
and periapical tissues.41 Endodontic therapy is dependent upon the successful removal of 
bacteria from the root canal system to allow the conditions for the body to heal the 
periapical tissues and to return the tooth to a homeostatic environment.   
In 1890 Miller demonstrated that the cause of apical periodontitis was due to the 
presence of different bacteria associated with pulpal disease.42 The landmark study for 
endodontics was in 1965 when Kakehashi et al. demonstrated that the pulps of germ-free 
rats survived despite being left open to the oral environment.43 This study showed the 
importance of bacterial presence in the formation of pulpal and periapical disease.44  
Without the reduction of bacteria, apical periodontitis can occur.45 This highlights the 
importance of chemo-mechanical cleaning and shaping of the root canal system. 
The importance of chemo-mechanical preparation, microbial control, and 
obturation were emphasized by Stewart in 1955.46 Of the three phases, chemo-
mechanical preparation was the most significant factor. 46 Grossman further expanded 
upon this concept of chemo-mechanical preparation when he described 13 principles of 
effective root canal therapy.47 The 13 principles consisted of47:  
1. Aseptic technique. 
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2. Confinement of instrumentation within the root canal system. 
3. A fine, smooth instrument should be used to enter the canal and never 
forced apically. 
4. Enlargement of the canal space from its original size with biomechanical 
instrumentation. 
5. The root canal space should be irrigated continuously with a solution that 
is aseptic during instrumentation. 
6. The irrigation solution should be non-irritating and remain within the 
canal space. 
7. No special treatment is needed for a fistula. 
8. Before obturation, a negative culture should be obtained. 
9. A hermetic seal of the root canal system should be obtained. 
10. Use of an obturation material that is not irritating to the periapical tissues. 
11. Drainage must be established if an acute alveolar abscess is present. 
12. Avoid injections into the area of an infection. 
13. Periapical surgery may be indicated to eliminate the inflammatory or 
cystic tissues. 
Schilder discussed how sealing the root canal system (by obturation of the root 
canal system in three dimensions, after chemo-mechanical preparation, to the cement-
dentinal junction or from 0.5 to 1 mm from the apex) would help protect the periapical 
tissues from breakdown from endodontic pathogens.48 Pitt Ford outlined three reasons for 
having a well-obturated root canal.49  The reasons he stated were49: 
1. Decreased space for bacterial colonization. 
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2. Prevention of bacterial contamination of the apex. 
3. Prevention of bacterial movement along the wall of the canal system. 
Ford also stressed the importance of maintaining an aseptic environment during 
treatment.49 
Weine in 1996 made alterations to the principles of endodontic therapy.41 His 
alterations included the need for restoration of endodontically treated teeth, diagnosis, 
preparation, obturation, importance of debridement, use of rubber dam, maintaining 
instrumentation to within the canal system, post-operative observation, and case 
presentation to the patient during treatment planning.41 Non-surgical endodontic therapy 
consists of debridement of the canal chemo-mechanically with endodontic files and 
irrigation solutions followed by obturation of the root canal system. 
 
IRRIGATION SOLUTIONS 
Roughly 35 percent of the root canal system remains uninstrumented after 
mechanical debridement with nickel-titanium rotary instruments.50 Schilder emphasized 
the importance of irrigation solutions in non-surgical endodontic therapy. 48 Bystrom and 
Sundqvist demonstrated in 1981 that bacteria still persisted even after treating canals 
mechanically and using saline irrigation.51 Such findings demonstrated the limitations of 
mechanical instrumentation without irrigation. Some teeth still had bacteria present after 
five treatment cycles.51 Several irrigation solutions are used to aid in the removal of more 
debris during chemo-mechanical preparation. Harrison outlined the properties of an ideal 
irrigation solution.52 They are: 
1. Efficacy as an antimicrobial agent. 
2. Ability to dissolve tissues. 
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3. Biocompatibility. 
4. Ability to aid in the debridement the root canal system. 
The main irrigation solutions used today are sodium hypochlorite (NaOCl), 
chlorhexidine (CHX), and ethylenediaminetetraacetic acid (EDTA). 
 
Sodium Hypochlorite 
 
NaOCl has been shown to be an effective antimicrobial agent with greater ability 
over saline for elimination of microorganisms from within the root canal system.53 
NaOCl is not available commercially around 8.0 percent and is diluted for clinical use to 
anywhere from 0.5 percent to 6.0 percent.54 At lower concentrations, NaOCl’s effect is 
primarily tissue-dissolving, and as the concentration increases, so does the ability to 
dissolve tissues, as well as to increase antimicrobial efficacy.55 Hand et al. found that full 
strength NaOCl, 5.25 percent was significantly better at dissolving pulp tissue remnants 
than lesser-concentrated forms.56 The tissue-dissolving ability is enhanced through longer 
duration and increases in temperature.57,58 NaOCl’s hypochlorite ion, OCl-, establishes an 
equilibrium with HOCl, hypochlorous acid, which is responsible for bacterial 
inactivation.59 NaOCl is considered the most effective irrigant for use in endodontics due 
to its desirable characteristics, including its antibacterial properties, its ability to dissolve 
necrotic tissues, its action to mechanically flush debris from within the root canal, and its 
lubricating ability.60,61 
 
Chlorhexidine 
Chlorhexidine (CHX) is an effective antimicrobial against gram-positive and 
gram-negative bacteria, facultative anaerobes and aerobes, spores, viruses and yeast.62 
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CHX is used in endodontics at two concentrations, 0.012 percent and 2 percent. The 
positive electrostatic charge of CHX binds to the negatively charged bacterial cell wall.  
This causes the cell wall to be disturbed, making it more permeable and diminishing the 
bacteria’s ability to regulate its internal environment.61,63 Unlike NaOCl, CHX has the 
ability to remain on dentin for long periods of time hindering the ability of bacteria to 
colonize surfaces.64 Rosenthal et al. in 2004 demonstrated that CHX remains within the 
root canal dentin and retains its antimicrobial activity for up to 12 weeks.65 CHX, just like 
NaOCl, is concentration-dependent. Two percent CHX has been shown to be more 
effective than 0.12-percent formulations.66 Due to many of these antimicrobial properties, 
CHX has been recommended as a final irrigant during endodontic treatment.67 
One reason that CHX is not used exclusively as an irrigant is due to its lack of 
tissue-dissolving properties. Using CHX as an adjunct to NaOCl has some drawbacks.  
One potential problem is when CHX and NaOCl are mixed. This can lead the 
precipitation of what was initially thought to be para-chloroaniline, a potential 
carcinogen.66 Later studies concluded that it was actually para-chlorophenylurea and 
para-chlorophenylguanidyl-1,6-diguanidyl-hexane.68 After irrigating with NaOCl and 
before a final rise with CHX, it is advised to use isopropyl alcohol69 to flush out NaOCl 
and diminish the potential for forming the precipitate.  
 
Ethylenediaminetetraacetic Acid (EDTA) 
A smear layer is formed during the mechanical debridement and shaping of the 
root canal. It is still not clear whether removal of this smear layer is beneficial or not.70 It 
has been suggested in a recent systematic review that the removal of the smear layer is 
actually beneficial in increasing the fluid-tight seal after obturation.71 The most effective 
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concentration for smear layer removal and deeper penetration of irrigation solutions has 
been shown to be 17 percent when used in conjunction with NaOCl. 72,73 Orstavik and 
Haapasolo demonstrated how EDTA can remove the smear layer and improve the 
antimicrobial effects of other irrigating solutions deeper into the dentin.74 Due to the 
possibility of an improved seal after obturation,71 EDTA has become a common irrigation 
solution during endodontic treatment.   
 
OBTURATION 
After thorough chemo-mechanical preparation, the root canal system needs to be 
sealed with a filling material. Obturation with gutta percha and sealer is the most widely 
used method. The goal of obturation is to hermetically seal the root canal to prevent re-
infection of the periapical tissues.75 Length of the obturation has been shown to affect the 
success of the obturation.76 The highest success rates were found in a meta-analysis when 
the obturation material was not found beyond the apex.76 The techniques used, and the 
anatomy of the tooth, play a role in controlling the length of the filling material. It has 
been shown that using warm gutta-percha impacts the likelihood of over-extending the 
obturation material past the apex.77 The last part involved in sealing the root canal system 
is the placement of a coronal restoration, which leads to the highest success rates.78  
 
REGENERATIVE ENDODONTICS 
The goal of endodontic therapy is to retain infected teeth by eliminating pulpal 
and periapical disease. Young, infected permanent teeth with incomplete development of 
the root pose significant challenges in endodontic treatment. Chemo-mechanical 
disinfection with conventional techniques, debridement with endodontic files, and 
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irrigation can be challenging, as well as obturation of the treated immature canal.1 RE 
procedures have become acceptable treatments for these teeth.  RE procedures can be 
defined as “biologically based procedures designed to replace damaged structures, 
including dentin and root structures, as well as cells of the pulp-dentin complex.”2 
Endodontic regenerative therapy aims to establish an environment that will enable 
continued root development, revascularization, and revitalization of the pulp tissue.  
Proper disinfection of the root canal system is a prerequisite for RE.3 
Stem cells, a scaffold, and cytokines/growth factors are three major components 
needed to create an environment for successful RE. Currently, a blood clot in the canal 
serves as an endodontic scaffold.4 Bleeding is evoked from the apical tissues and a blood 
clot is created in the canal. The evoked-bleeding step involves the manipulation of the 
periapical tissues; stem cells are released and delivered into the root canal system.5 
Soluble extracellular matrix molecules of dentin, pulp fibroblasts, and ECs have also 
been shown to be involved in dentin-pulp regeneration6 and may enter with the blood 
clot. The blood clot scaffold is eventually replaced with pulp-like tissue; dentin and pulp 
regeneration can be seen, as well as continued root development.6 
RE procedures are not entirely new ideas within endodontics. The recent work by 
Iwaya in 2001 has increased the interest in RE within the dental community.79 The article 
explained through a case report the treatment of a 13-year-old female’s mandibular 
second premolar with a sinus tract and immature root development. The tooth was 
irrigated with NaOCl (5 percent) and hydrogen peroxide (3 percent). A combination of 
metronidazole and ciprofloxacin was used for further disinfection. Finally, calcium 
hydroxide was placed apically against the tissues, and the access was closed with glass-
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ionomer cement and a resin composite restoration. The 30-month follow-up revealed 
continued root development.79 The case report sparked interest in development of a 
clinical protocol to maximize the clinical success.   
Case selection is a key component for success in RE. The American Association 
of Endodontists (AAE) discuss in their AAE Clinical Considerations for a Regenerative 
Procedure the case selection and procedure for RE.13 Case selection involves four parts 
including: the tooth should be necrotic with an immature apex; a post space is not needed 
for the final restoration; compliance of the patient and parent, and the patient is not 
allergic to any of the medicaments and antibiotics needed for the procedure.  Once a case 
is deemed appropriate, the AAE has developed a current clinical protocol.12  
The current protocol involves two appointments. At the first appointment, the 
tooth is irrigated copiously with gentile irrigation of 20 ml of 1.5 percent NaOCl. 80 CHX 
is not recommended for RE procedures due to its cytotoxic effects on stem cells of the 
apical papilla.81 The canals are dried, and either calcium hydroxide or antibiotic paste is 
placed into the canal, and the tooth, sealed with a temporary restoration. The second visit 
is initiated within one to four weeks. At this visit, the use of 20 ml of 17-percent EDTA is 
recommended.81,82 EDTA has been shown to promote the survival of stem cells of the 
apical papilla (SCAP), potentially by promoting dental growth factors to be released from 
the dentin.2,83 A blood clot is then induced and currently serves as an endodontic scaffold 
for continued root development.4 A scaffold is very important for RE procedures.  
Scaffolds provide the environment necessary for “cell growth and differentiation, 
promoting cell adhesion, and migration.”84 This is induced by laceration of the apical 
tissues with the goal of blood clot formation to the cement-enamel junction allowing for 3 
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mm to 4 mm of mineral trioxide aggregate (MTA) to be placed to seal the root canal.  A 
final restoration is then placed over the MTA.13 Failures in RE have been attributed to a 
lack of vascularization, which could not support the blood clot scaffold.7  
 
ANGIOGENESIS 
Angiogenesis, the development of new blood vessels, is needed to increase 
vascularization, and the creation of a vascular network. Capillary development occurs in 
three different ways. They can sprout from existing capillaries, anew, and by 
“incorporating circulating monocytes that have transdifferentiated into endothelial 
cells.”9 Sprouting angiogenesis is the most studied form of angiogenesis.8 A need exists 
for a balance with angiogenesis to prevent a state of chronic inflammation associated 
with fibroproliferative disorders and metastasis tumors.85 
Different cell types and various cytokines/growth factors are involved in 
angiogenesis. These include endothelial cells, fibroblasts, neutrophils, and macrophages 
that produce vascular endothelial growth factor (VEGF).  VEGF is a signaling protein 
that early in angiogenesis increases the permeability of blood vessels causing the 
extravasation of plasma proteins. This step leads to the creation of a temporary scaffold 
for migrating ECs.8 Macrophages produce tumor necrosis factor alpha (TNF-alpha), 
which also induces VEGF expression. In wound repair, VEGF expression is enhanced 
leading to a neovascular network that drives regeneration by increasing tissue perfusion.9 
ECs have been shown to release the angiogenic cytokines fibroblast growth factor (FGF) 
and VEGF without any stimulation.6 VEGF increases the permeability of ECs and FGF 
promotes the proliferation and differentiation of ECs, smooth muscle cells, and 
fibroblasts.  
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Matrix metalloproteinases (MMPs) play a role in angiogenesis by degrading 
extracellular matrix molecules and by activating or liberating the growth factors bFGF, 
VEGF, and insulin-like growth factor 1 (IGF-1) that are within the extracellular matrix.8 
Zehng et al. showed an increase in the expression of MMP-3, MMP-9, and MMP-13 after 
a pulpal injury.10 Tissue inhibitors of matrix metalloprotienases (TIMPs) play a role in 
the inhibition of MMPs and therefore inhibit angiogenesis. Mathieu et al. showed that 
ECs might play an important role in recruiting human pulp cells, as well as in forming the 
necessary blood vessels for angiogenesis.11 It is believed that an appropriate scaffold that 
will provide an environment that will support ECs may improve the success of RE 
procedures.    
 
SCAFFOLDS  
There are multiple scaffolds used in place of a blood clot. The most commonly 
used alternative scaffolds are platelet-rich-plasma, synthetic and natural scaffolds.12 
DynaMatrix® (Cook Biotech, West Lafayette, IN) is a matrix currently used in dentistry 
for periodontal regeneration procedures.12,13 This ECM is derived from porcine small 
intestine submucosa (SIS) and is composed of collagen that could be used as a framework 
for cell growth. The intestine is processed with surfactant and ionic solutions to remove 
the cells and nuclear matter. The remaining structure is three-dimensional, acellular, and 
collagen-rich with no cross-linking. An isolation process preserves the structural 
components of the matrix consisting of collagens I, III, IV, and VI.  The result is a 
framework for infiltration of cells, cytokines, and MMPs important for regeneration. The 
company states that it contains promoters of angiogenesis including FGF-2, connective 
tissue growth factor (CTGF), and transforming growth factor beta (TGF-betta).13 
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Research at Indiana University School of Dentistry (IUSD) has shown that DynaMatrix® 
has potential as an endodontic scaffold.14,15 It can support the growth of HDPSCs and 
HPFs. Positive angiogenic profiles were seen after these cells were exposed to 
Dynamatrix®. The effects of Dynamatrix on EC, cytokines, and MMPs have not been 
investigated, although both are pivotal for angiogenesis. This work will further the 
evidence for the potential Dynamatrix has in RE.  
RE procedures will continue to change and evolve as futures studies continue to 
enhance the understanding of the important factors needed. With this, the protocols used 
will continue to change, to increase the outcomes, and to enhance predictability. 
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METHODS AND MATERIALS 
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EXPERIMENTAL DESIGN 
Human umbilical vein endothelial cells (HUVECs) were utilized in this in-vitro 
study. The study groups were as follows: 1) HUVECs seeded in culture only (control 
group 1); DynaMatrix® membranes in culture media without any cells (control group 2); 
and HUVECs seeded on DynaMatrix® membranes (experimental group). Conditioned 
media from the different groups were collected after 72 hours of incubation. The media 
were tested for the expression of specific cytokines and matrix metalloproteinases.   
 
HUVECs CULTURE 
 The HUVECs were obtained from American Type Culture Collection (ATTC, 
Manassas, VA, USA) and grown in Kaighn’s Modification of Ham’s F-12 with L-
Glutamine (ATTC, Manassas, VA) supplemented with 0.1 mg/ml heparin, 0.03 mg 
endothelial cell growth supplement (EGGS), 10-percent solution of fetal bovine serum 
(FBS), 100 U/ml penicillin, 50-mg/ml gentamicin, and 2.5-mg/ml of amphotericin B.  
HUVECs from passage 3 to passage 8 were used.  HUVECs were grown, and visual 
inspection under the microscope confirmed the cell count.  
 
HUVEC TREATMENT 
After the HUVECs were grown, 75,000 cells were seeded per well in six well 
plates. Three wells were used for each group for a total of 9 wells. The experimental 
groups tested were as follows:  
(a) Group 1: HUVECs only (C). 
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(b) Group 2: DynaMatrix® membrane incubated without any cells (M), and 
(c) Group 3: HUVECs seeded on DynaMatrix® membranes (C+M). 
The experimental design is shown in FIGURE 1. 
The cells were given 24 hours for attachment and verified with a light 
microscope. The serum plus media was removed and 2 mLs of serum minus media was 
added to each well of the 6 well plates. Then, after 72 hours of incubation at 37°C, the 
conditioned media from the three different experimental groups were collected and stored 
at -70oC until analyzed.  The conditioned media from the various groups were used to test 
for the expression of multiple angiogenic cytokines and MMPs.  
 
ANGIOGENIC CYTOKINE AND MMP EXPRESSION 
Equal volumes, 1 mL of conditioned media, were used for analyses. The 
angiogenic cytokine and MMP profile from HUVECs alone or HUVECs seeded on 
DynaMatrix® membranes or membranes alone were evaluated utilizing RayBio Human 
Angiogenesis Antibody Array I (TABLE 1, RayBiotech Inc., Norcross, GA) and 
RayBio® Human Matrix Metalloproteinase Antibody Array (TABLE 2, RayBiotech Inc., 
Norcross, GA) according to the manufacturer’s protocol. Specifically, the array 
membranes were blocked by 1 ml of the blocking buffer, supplied by the kit, for 30 
minutes. The blocking buffer was removed. Then, 1 ml of the conditioned media was 
added to each well and incubated overnight at 4°C. The membranes were then washed 
three times with 2 ml of Buffer I for five minutes, then washed twice with 2 ml of  Buffer 
II for 5 minutes. Then, 1 ml of the Biotinylated Antibody Coctail was then added to each 
well and incubated overnight at 4°C.  The membranes were then washed with Buffer I 
and II as previously described.  Then, 2 ml of Horseradish Peroxidase-Conjugated 
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Streptavidin was added to each well and incubated for 2 hours at 4°C.  The wells were 
then washed with Buffer I and Buffer II again as previously described. Detection agent 
supplied by manufacturer was added and then the membranes were exposed to X-ray film 
for 5 seconds, 10 second, 20 seconds, 30 seconds and 2 minutes. The density of the 
cytokine expression was measured with the Quantity One 1-D Analysis Software (Bio-
Rad Laboratories Inc., Hercules, CA).  The experiment was repeated three times and the 
averages calculated.  
 
STATISTICAL ANALYSIS 
Multiple dots for each cytokine on array membranes were averaged. For each 
array membrane, the densities were adjusted for the background by subtracting the 
average value of the negative controls and then normalized by dividing by the average of 
the positive controls.The data were then converted back to the original scale by 
multiplying by the average of the positive controls for the first array membrane. Group 
comparisons were performed using one-way analysis of variance (ANOVA) followed by 
pair-wise tests using Fisher’s Protected Least Significant Differences to control the 
overall significance level at 5 percent. Analyses were performed using SAS (SAS 
Institute Inc., Cary, NC). The distribution of the data was examined and a transformation 
of the data (natural logarithm, rank, etc.) was used. Based on previous studies, the study 
has approximately 80-percent power to detect a three-standard-deviation difference 
between groups, assuming two-sided tests each conducted at a 5-percent significance 
level.  
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The Quantity One 1-D Analysis Software (Bio-Rad) was used to measure the 
optical densities of the visible dots on the membranes. The background for each 
membrane was adjusted. The average value of the negative controls was subtracted and 
then normalized by dividing the average of the positives controls. There were three 
membranes for each group. Group comparisons were done utilizing a one-way ANOVA. 
The cytokine and MMP arrays showed that the cells alone had significantly 
greater GRO (p = 0.0123); MCP-1 (p = 0.0123); MMP-1 (p = 0.0300); MMP-2 (p = 
0.0254); MMP-10 (p = 0.0003); MMP-13 (p = 0.0186); TIMP-1 (p = 0.0254); and TIMP-
2 (p = 0.0003) as compared with the membrane alone. The membrane alone had 
significantly less MMP-8 (p = 0.0308) when compared with cells alone. 
The cells + membrane showed significantly greater values for bFGF (p = 0.0065) 
than the cells alone. The cells + membrane showed significantly smaller MMP-10 (p = 
0.0104) and TIMP-2 (p = 0.0104) than the cells alone. The cells + membrane showed 
significantly smaller values than the cells alone for MMP-8 (p = 0.0065). 
Cells + membrane showed significantly greater bFGF (p = 0.0308); GRO (p = 
0.0300); Leptin (p = 0.0186); MCP-1 (p = 0.0300); MMP-1 (p = 0.0123); MMP-2 (p = 
0.0190); MMP-10 (p = 0.0104); TIMP-1 (p = 0.0190), and TIMP-2 (p = 0.0104) 
compared with the membrane alone. 
The cytokine array groups did not have significantly different values for ANG (p 
= 0.0945); EGF (p = 0.7843); ENA-78 (p = 0.2042); IFN-γ (p = 0.9670); IGF-1 (p = 
0.7843); IL-6 (p = 0.0945); IL-8 (p = 0.1424); PDGF-BB (p = 0.4910); PIGF (p = 
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0.1424); RANTES (p = 0.7290); TGF- ß1 (p = 0.7290); TIMP-1 (p = 0.1820); TIMP-2 
(0.1820); Thrombopoietin (p = 0.9670); VEGF (p = 0.7843), and VEGF-D (p = 0.4910). 
The MMP array groups did not have significantly different values for MMP-3 (p 
= 0.6262); MMP-9 (p = 0.1424), and TIMP-4 (0.7843). 
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FIGURE  1. Experimental design. 
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FIGURE 2. DynaMatrix membrane sterilized. 
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FIGURE 3.   Example of DynaMatrix trimmed to fit into the six-well plate. 
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FIGURE 4.  Six-well plates with three experimental groups with culture media. 
Column 1:  HUVECs; Column 2: HUVECs seeded on DynamMatrix; 
and Column 3:  DynaMatrix membrane. 
37	  
	  
 
 
 
 
 
 
    
FIGURE 5.  Array membranes placed in wells. 
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C+M         C         M 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6.  Cytokine array: Images of scanned x-ray films for each sample group.  
From left to right:  Cell+Membrane group (C+M); Cell-only group (C); 
and Membrane-only group (M). 
.  
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       C+M                                         C                    M 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 7.  MMP Array: Images of scanned x-ray films for each sample group. From 
left to right: Cell+Membrane group (C+M); Cell-only group (C); and 
Membrane-only group (M). 
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TABLE I 
 
Key to abbreviations: 
Angiogenin: aka ribonuclease 5 
EGF: epithelial growth factor 
ENA-78: epithelial neutrophil-activating protein 78 
b FGF: basic fibroblast growth factor 
IFN-γ: interferon gamma 
IGF-1: insulin-like growth factor 1 
IL-6, 8: interleukin 6,8 
MCP-1: monocyte chemotactic protein-1 
PDGF-BB: platelet-derived growth factor BB 
PIGF: Phosphatidylinositol-glycan biosynthesis class F protein 
TGF-β1: transforming growth factor beta 1 
TIMP-1, 2: tissue inhibitor of metalloproteinases metallopeptidase inhibitor 1, 2 
VEGF: vascular endothelial growth factor 
VEGF-D: vascular endothelial growth factor D 
POS: positive control 
Neg: negative control 
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TABLE II 
            RayBio® human matrix metalloproteinase antibody array  
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TABLE III  
Data summary of densitometry readings for cytokine array* 
Cytokine C M C+M 
ANG 60012 (39064) -42846 (43058) 129372 (46287) 
bFGF -45220 (44510) -35128 (43536) 97693 (78019) 
EGF -43021 (43730) -41951 (42880) 85810 (86806) 
ENA-78 -39696 (47252) -41950 (42965) 88730 (84731) 
GRO 173462 (65497) -40415 (44717) 158113 (18553) 
IFN-γ -40894 (45054) -41232 (44346) 86219 (87205) 
IGF-1 -42763 (43699) -40964 (43968) 85427 (87313) 
IL-6 4144 (44794) -41429 (43553) 108037 (63924) 
IL-8 383171 (88302) -40512 (43016) 310150 (157215) 
LEPTIN -22429 (49056) -39917 (42737) 108537 (68966) 
MCP-1 271193 (81018) -39463 (42372) 232402 (57627) 
PDGF-
BB -39535 (44622) -40165 (43670) 90897 (84240) 
PIGF -7179 (50997) -41561 (45001) 101250 (72780) 
RANTES -38922 (44416) -36873 (45059) 87397 (85444) 
TGF-ß1 -41043 (44427) -39061 (43882) 86942 (84810) 
TIMP-1 80033 (56341) -40506 (43999) 141514 (27625) 
TIMP-2 68683 (47678) -40539 (43756) 103968 (67456) 
Thrombo -41778 (43985) -40783 (43005) 86135 (85737) 
VEGF -41152 (44959) -39576 (43038) 87670 (85237) 
VEGF-D -43629 (44308) -39307 (44125) 86798 (85988) 
 
*Mean densitometry values for each experimental group, followed by the 
standard error in parenthesis. C: Cells only; M: DynaMatrix only; M+C:  
HUVEC seeded on DynaMatrix. 
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TABLE IV  
Data summary of densitometry readings for the MMP array* 
MMP C M C+M 
MMP-1 268750 (33511) 26630 (2003) 286894 (5036) 
MMP-2 20151 (3619) 12482 (786) 17727 (1042) 
MMP-3 24321 (3302) 21833 (1137) 25248 (2396) 
MMP-8 -4 (523) -1983 (732) -2711 (578) 
MMP-9 22341 (505) 17458 (3451) 15360 (553) 
MMP-10 266741 (16450) -1805 (861) 95033 (7677) 
MMP-13 21932 (1797) 16407 (1296) 19288 (1231) 
TIMP-1 212466 (28199) -432 (668) 223384 (8775) 
TIMP-2 200826 (26425) 10493 (1460) 73484 (4112) 
TIMP-4 21493 (2942) 23444 (455) 24275 (1030) 
 
*Mean densitometry values for each experimental group, followed by the 
standard error in parenthesis. C: Cells only; M: DynaMatrix only; M+C: 
HUVEC seeded on DynaMatrix. 
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DISCUSSION 
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HUVECs seeded on the DynaMatrix in vitro grew on the membranes. This 
important characteristic makes DynaMatrix a possible future scaffold to be placed within 
the canal during regenerative endodontic procedures.  
In this in-vitro study, the HUVECs only group (C) had statistically significant 
greater values for GRO and MCP-1 in the cytokine array, and MMP-1, MMP-2, MMP-
10, MMP-13, TIMP-1 and TIMP-2 in the MMP array as compared with the DynaMatrix 
only group (M).  
The experimental group (C + M) had a statistically significant increase in bFGF, 
GRO, Leptin, and  MCP-1 in the cytokine array, and a significant increase in the MMP 
array of MMP-2, MMP-10, TIMP-1 and TIMP-2 compared with the DynaMatrix 
membrane alone. HUVECs alone also were more significant than the DynaMatrix 
membrane alone for GRO and MCP-1 in the cytokine array and also for MMP-2, MMP-
10, MMP-13, TIMP-1 and TIMP-2 in the MMP array. This could imply an additive effect 
of the cells on the DynaMatrix for GRO, MCP-1, MMP-2, MMP-10, TIMP-1 and TIMP-
2.   The DynaMatrix membrane did not express many factors, therefore, the addition of 
the cells to the membrane appears to be an additive effect for many factors in the arrays.   
The most significant changes were seen within the C+M group compared with the 
cells only group. The HUVECs seeded on the DynaMatrix membrane group (C+M) had 
statistically significant increases in the expression of bFGF versus both control groups in 
the cytokine array. This increase is not due to simple addition of bFGF through leaching 
of the cytokine from the membrane alone. The levels of bFGF in the experimental group 
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(C+M) were shown to be statistically significantly greater than those of the membrane or 
the cells alone. The level of bFGF in the experimental group could be due to a 
stimulatory effect of the DynaMatrix on the HUVECs. It appears to be more than just an 
additive effect due to the significant level of increase in bFGF in the experimental group. 
Membrane-only specimens had greater levels of bFGF than the cells alone, but were not 
statistically significant. The membrane-only group had no HUVECs present; therefore, 
the increase in bFGF in the supernatant of the membrane-only group must be a result of it 
leaching from the membrane.   
 The experimental group (C + M) has significantly less TIMP-2 and MMP-10 
than the cells alone in the MMP array. The importance of TIMP-2 being statistically 
significantly less implies that the membrane had an inhibitory effect on the cells ability to 
release/express TIMP-2.  
 An interesting finding was that the cytokine array did show a difference between 
the C+M group and the C group for TIMP-2.  TIMP-2 was less in the C+M group, but 
was not shown to be statistically significant.   
The overall results of this study were an increase in pro-angiogenic cytokines and 
MMPs. The increase in bFGF in the experimental group was the only cytokine to 
increase compared with both. A pro-angiogenic cytokine, the bFGF promotes 
proliferation and differentiation of endothelial cells, smooth muscle cells, and fibroblast. 
Purified basic pituitary FGF in vitro has been shown to “induce endothelial cells to 
invade three-dimensional collagen matrix and to organize themselves to form 
characteristic tubules that resemble blood capillaries.”86 Studies have shown that bFGF 
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can stimulate characteristics of the processes for angiogenesis for inducing endothelial 
cell migration and invasion.86  
The other cytokines that were shown to be statistically increased in the 
experimental group were compared with the membrane-only group. They were GRO, 
Leptin, and MCP-1. GRO has been shown to be a chemotactic factor for angiogenesis, as 
well as MCP-1, which is recognized as an angiogenic chemokine. Leptin is an endocrine 
hormone that regulates adipose tissue, and it has been found to generate a growth signal 
to promote angiogenic processes in endothelial cells via a leptin receptor.87 It has been 
speculated that in addition to stimulating angiogenesis in ECs via a leptin receptor, 
“leptin plays a role in matrix remodeling by regulating the expression of MMPs and 
TIMPs.”87  
The MMPs arrays had several factors that were shown to be statistically decreased 
in the C+M group compared with the C group. The experimental group had a decrease in 
TIMP-1 compared with the cells alone. The experimental group compared with the 
membrane alone had an increase in TIMP-1 and TIMP-2.  The membrane-only group had 
very small values for TIMP-1 and TIMP-2 as compared with the cells-only group and 
could account for the increase in the experimental group compared with the membrane- 
only group. The decrease in TIMP-2 demonstrated that the membrane might have an 
inhibitory effect on the cells’ expression of TIMP-2.  The increase in TIMP-1 and TIMP-
2 compared with the membrane-only group could be due to the addition of cells to the 
membrane having an additive effect as compared with the membrane-only, because the 
membrane-only group had a very small value for TIMP-1 and TIMP-2. TIMP-1 and 
TIMP-2 are known to inhibit all known MMPs, therefore inhibiting the degradation of 
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ECM and preventing angiogenesis from occurring.88 It would be a desired outcome to 
have an overall decrease in TIMPs to prevent inhibition of MMPs and therefore to help 
promote angiogenesis. 
The MMP array’s decrease in MMP-10 in the experimental group compared with 
the cells-alone group is not a desired outcome, due to its ability to degrade the ECM and 
promote angiogenesis; however, the expression of many other MMPs were not negatively 
affected by the addition of the membrane. This decrease could be due to an inhibitory 
effect the membrane has on the cells’ ability to express MMP-10. The experimental 
group had an increase in MMP-2 and MMP-10 compared with the membrane-only group. 
This could be due to an additive effect of the cells to the membrane because these MMPs 
were not increased compared with the cell-only group. MMPs have been shown to play 
an important role in angiogenesis, wound healing, and inflammation.10 They also 
contribute to the remodeling of pulp tissues and dentin.68,90  Several inflammatory 
cytokines have been shown to stimulate MMP-10.69 The decrease in MMP-10 may not 
inhibit angiogenesis in the presence of inflammation within the canal. 
It is difficult to know for sure if the preceding discussion regarding specific 
cytokines and MMPs observed in-vitro would correlate to an in-vivo setting. The 
individual cytokines and MMPs are affected by many different factors. They can have 
different effects based on their target cells, and they are dose dependent. Much of the 
research on the angiogenic potential of the cytokines and MMPs has been done with a 
focus on tumor angiogenesis. The findings in these studies may focus on different clinical 
conditions than those of the present study, and therefore, the outcomes may differ 
clinically from the regenerative endodontic procedures that we focused on.   
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Research at IUSD has focused on the use of DynaMatrix as a scaffold in RE 
regenerative endodontic procedures. The previous studies used HDPSC and HDPF.  The 
results of these studies were that there were statistically significant differences in the 
expression of angiogenic cytokines in the experimental groups (HDPSC or HDPF seeded 
on DynaMatrix) when compared with the control groups (HDPSC or HDPF only and 
DynaMatix only).14,15  The use of a matrix may allow for a more coronal advancement of 
the factors necessary for regeneration either by a wicking effect, or by increasing 
angiogenesis to the level of the scaffold. Failures in RE have been linked to the lack of 
vascularization within the canal that could support the blood clot scaffold, 7 and using a 
scaffold like DynaMatrix may be a solution to this problem.   
Future studies could include evaluating the angiogenic cytokine effects of 
HDPSC, HDPF, and HUVECs on the DynaMatrix. Eventually animal studies could be 
done leading to in-vivo human studies based on the fact that DynaMatrix is currently used 
in dentistry and medicine as an FDA-approved resorbable membrane.    
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SUMMARY AND CONCLUSIONS 
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The null hypothesis for this study was rejected. There was a statistically 
significant increase in bFGF in the experimental group (HUVECs seeded on Dynamatrix) 
as compared with the control groups (HUVECs alone and DynaMatrix alone). In addition 
to bFGF, Leptin, MCP-1, GRO, MMP-2, and MMP-10 were also increased in the 
experimental group compared with the membrane alone. Other factors, like TIMP-2, 
were decreased in the experimental group as compared with the cells alone, but increased 
in the experimental group compared with the membrane alone. Overall, the cytokine and 
MMP profiles are positive for up-regulation of pro-angiogenic factors and down- 
regulation of some anti-angiogenic factors.  
This study adds to the overall evidence that supports the use of DynaMatix for an 
intracanal scaffold for regenerative endodontics. DynaMatrix could increase the local 
angiogenic cytokines, specifically bFGF, and MMPs within the canal. The membrane 
may also assist in endodontic regeneration by down-regulation of TIMP-2, an inhibitor of 
angiogenesis, in the presence of ECs. It could also serve as a more predictable and 
reproducible scaffold clinically. This study demonstrated that DynaMatrix could support 
the growth of endothelial cells. The overall results of this study suggest that DynaMatrix 
could improve the vascularization within the canal by changing the microenvironment 
within the disinfected canal and allow for angiogenesis and tissue regeneration. 
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EFFECTS OF DYNAMATRIX® ON ANGIOGENIC CYTOKINE 
 AND MATRIX METALLOPROTEINASE EXPRESSION  
FROM HUMAN ENDOTHELIAL CELLS: 
 AN IN-VITRO STUDY 
 
 
 
 
 
by 
 
Scott Thomas Hill 
 
Indiana University School of Dentistry 
Indianapolis, IN 
  
 Introduction: Regenerative endodontics (RE) is a treatment alternative for the 
infected immature tooth to establish an environment in the canal that enables continued 
root development and the growth of pulp or pulp-like tissue within the canal. A scaffold 
created in the canal encourages the formation of vital tissue. The porcine sub-intestinal-
submucosa (SIS) membrane, Dynamatrix®, has the potential to serve as an endodontic 
scaffold.  Research at Indiana University School of Dentistry (IUSD) has shown that 
Dynamatrix® can support the growth of human dental pulp stem cells (HDPSC) and 
human pulp fibroblasts (HPF).  Positive angiogenic cytokine profiles were seen after 
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these cells were seeded on Dynamatrix®. Endothelial cells play an important role in the 
formation of blood vessels and are a source of angiogenic cytokines. Exposure of these 
cells to DynaMatrix® may result in a positive angiogenic profile for both cytokines and 
matrix metalloproteinases (MMPs).   
 Objective: The aim of this in-vitro study was to investigate if the exposure of 
human endothelial cells to the DynaMatrix® membrane would result in differences in the 
expression of cytokines and MMPs that play roles in angiogenesis.   
 Materials and Methods: Human endothelial cells (HUVECs) were obtained from 
American Type Culture Collection (ATTC, Manassas, VA) and used in this study. 
Groups were established as follows: (a) Group 1: HUVECs seeded in culture media only,  
(b) Group 2: DynaMatrix® membrane incubated alone in the serum-media without any 
cells, and (c) Group 3: HUVECs seeded on DynaMatrix® membranes. After 72 hours of 
incubation, the conditioned media were collected and analyzed for the expression of 20 
angiogenic cytokines and MMPs utilizing cytokine and MMP protein arrays. The density 
of each cytokine and MMP expressed was measured, averaged, and statistically analyzed 
by ANOVA.   
 Results: Exposure of human umbilical vein endothelial cells (HUVECs) to the 
DynaMatrix® membrane resulted in a positive angiogenic profile for both cytokines and 
MMPs.   
 Conclusion: This work furthers the evidence for the potential of DynaMatrix® to 
serve as a more predictable scaffold in RE. 
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